Research
Metabolic adaptation
Tirzepatide resulted in mean waist circumference reductions ranging from 4.3 to 9.8 cm across subgroups.
Tirzepatide is effective in reducing waist circumference in East Asian individuals with type 2 diabetes.
StrongSupportsmedium confidence
Mean waist circumference reductions ranged from 4.3 to 9.8 cm.
Why this rating
Based on the phase 3 clinical trial data presented in the abstract.
Source
Safety and efficacy analyses across age and body mass index subgroups in East Asian participants with type 2 diabetes in the phase 3 tirzepatide studies ( <scp>SURPASS</scp> programme)
Arihiro Kiyosue et al. · Diabetes Obesity and Metabolism · 2022
rctCited 24×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →